Evaluation of an Oral Nutritional Supplement Containing AN777

Inclusion Criteria: Subject (male or female) is \> or equal to 65 and \< or equal to 90 years of age Subject is ambulatory Subject has a Subjective Global Assessment of B or C Subject has gait speed \<0.8 m/s AND/OR low hand-grip strength Subject has Class 1 or Class 2 sarcopenia Subject agrees to refrain from starting a resistance exercise program Exclusion Criteria: Subject has type 1 or type 2 diabetes Subject has inflammatory disease with elevated high sensitivity C-reactive protein Subject has renal function impairment Subject reports gastrointestinal disorder (severe chronic diarrhea, nausea, vomiting) that would preclude ingestion of the study product; an obstruction of the gastrointestinal tract, inflammatory bowel disease; short bowel syndrome or other major gastrointestinal disease Subject reports of current active malignant disease or other significant medical diagnoses. Subject reports a history of allergy to any of the ingredients in the study products Subject reports currently taking medications/dietary supplements/substances that could profoundly modulate metabolism or weight.